Alabama STEM News
SEE OTHER BRANDS

Keeping up with science and technology news from Alabama

Alabama STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alabama STEM News.

Press releases published on June 24, 2025

Cellectar Biosciences Submits Phase 1b Clinical Trial Protocol to US Food and Drug Administration for CLR 125 to Treat Triple-Negative Breast Cancer (TNBC)

Cellectar Biosciences Submits Phase 1b Clinical Trial Protocol to US Food and Drug Administration for CLR 125 to Treat Triple-Negative Breast Cancer (TNBC)

Good Tolerability and Robust Tumor Uptake were Observed in TNBC Animal Models Auger Emitters Offer the Potential Benefit of Enhanced Cytotoxicity, Safety and Ease-of-Use FLORHAM PARK, N.J., June 24, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. ( …

Primech AI, a Subsidiary of Primech Holdings, Expands to the Hong Kong Market Through a Strategic Partnership with ReMining Ai Ltd.

Primech AI, a Subsidiary of Primech Holdings, Expands to the Hong Kong Market Through a Strategic Partnership with ReMining Ai Ltd.

SINGAPORE, June 24, 2025 (GLOBE NEWSWIRE) -- Primech AI Pte. Ltd. (“Primech AI” or the “Company”), a subsidiary of Primech Holdings Limited (Nasdaq: PMEC), today announced the signing of a strategic partnership with Hong Kong-based ReMining Ai Ltd to …

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

Vancouver, Canada, June 24, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …

Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹⁶¹Tb-KLK3-mAb Phase I Clinical Trial in Australia

Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹⁶¹Tb-KLK3-mAb Phase I Clinical Trial in Australia

RAD 402 preclinical data package complete; demonstrates safety and promising biodistribution profile Ethics approval and Phase 1 clinical trial start in prostate cancer anticipated in 2H 2025 SYDNEY and BUNDOORA, Australia, June 24, 2025 (GLOBE NEWSWIRE) …

Celebrate Innovation in Education at ISTELive 25 with zSpace

Celebrate Innovation in Education at ISTELive 25 with zSpace

SAN JOSE, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- zSpace (NASDAQ: ZSPC) (“zSpace” or the “Company”), a leading provider of augmented and virtual reality solutions for education, today announced its participation in the ISTE Live 25 Conference, taking …

SIOS Technology Announces Strategic Partnership with FCS InfoTech to Deliver High Availability and Disaster Recovery Solutions Across India and the GCC Region

SIOS Technology Announces Strategic Partnership with FCS InfoTech to Deliver High Availability and Disaster Recovery Solutions Across India and the GCC Region

SAN MATEO, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- SIOS Technology Corp., a leading provider of application high availability (HA) and disaster recovery (DR) solutions, today announced a strategic partnership with FCS InfoTech, a rapidly growing IT …

Starton Therapeutics and Bend Bioscience Enter into Development Agreement for Oral Controlled Release Dosage Form of STAR-LLD (lenalidomide)

Starton Therapeutics and Bend Bioscience Enter into Development Agreement for Oral Controlled Release Dosage Form of STAR-LLD (lenalidomide)

PARAMUS, N.J., June 24, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technologies, today announced a collaboration …

ClearScale Appoints Matt Stoyka as CEO, Names Jimmy Chui Chief Client Officer

ClearScale Appoints Matt Stoyka as CEO, Names Jimmy Chui Chief Client Officer

SAN FRANCISCO, June 24, 2025 (GLOBE NEWSWIRE) -- ClearScale, a leader in cloud modernization and an Amazon Web Services (AWS) Premier Tier Services Partner, today announced a leadership transition designed to accelerate growth and deepen client …

Byrna Technologies to Report Fiscal Second Quarter 2025 Financial Results on Thursday, July 10, 2025 at 9:00 a.m. ET

Byrna Technologies to Report Fiscal Second Quarter 2025 Financial Results on Thursday, July 10, 2025 at 9:00 a.m. ET

ANDOVER, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security …

Medera’s Novoheart Enters New Collaboration to Develop Human Mini-Heart Models Aimed at Transforming Treatment for Hypoplastic Left Heart Syndrome

Medera’s Novoheart Enters New Collaboration to Develop Human Mini-Heart Models Aimed at Transforming Treatment for Hypoplastic Left Heart Syndrome

First-ever mini-Heart models will be created from hypoplastic left heart syndrome (HLHS) patient stem cells, enabling personalized insights into their causes and treatments Partnership aims to improve survival and quality of life for pediatric HLHS …

SELLAS Life Sciences to be Added to Russell 3000® and Russell 2000® Indexes

SELLAS Life Sciences to be Added to Russell 3000® and Russell 2000® Indexes

NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …

Pioneering New Study Finds Most U.S. Babies Lack Key Gut Bacteria, Increasing Risk for Allergies and Other Chronic Health Issues

Pioneering New Study Finds Most U.S. Babies Lack Key Gut Bacteria, Increasing Risk for Allergies and Other Chronic Health Issues

Initial findings published today in Communications Biology - a Nature portfolio journal - show that 76% of infants in the U.S. are deficient in Bifidobacterium, a gut microbiome genus responsible for the utilization of human milk oligosaccharides (HMOs) …

Report Reveals Candidates’ Perspectives on Using AI in the Hiring Process

Report Reveals Candidates’ Perspectives on Using AI in the Hiring Process

DENVER, June 24, 2025 (GLOBE NEWSWIRE) -- In today’s high-pressure hiring environment, where talent teams are expected to do more with less, Employ Inc. remains committed to delivering innovative, intelligent hiring solutions that meet the real-world needs …

Senior Developer Hiring Trends: Human Skills To Outshine Technical Expertise, Says BairesDev CEO at World Economic Forum

Senior Developer Hiring Trends: Human Skills To Outshine Technical Expertise, Says BairesDev CEO at World Economic Forum

MOUNTAIN VIEW, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- As waves of AI-driven disruption transform the global workforce, one thing is clear: for senior software developers, tech skills might open doors, but soft skills lead the way. That was the message …

Aardvark Therapeutics to Join Prader-Willi Syndrome Community at the 2025 United in Hope Conference

Aardvark Therapeutics to Join Prader-Willi Syndrome Community at the 2025 United in Hope Conference

SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the …

PharmaTher Secures Key US Patent for Ketamine in Amyotrophic Lateral Sclerosis (ALS), Bolstering its Orphan Drug Designated Program and Targeting a Billion Dollar Market

PharmaTher Secures Key US Patent for Ketamine in Amyotrophic Lateral Sclerosis (ALS), Bolstering its Orphan Drug Designated Program and Targeting a Billion Dollar Market

TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("PharmaTher" or the "Company"), a company focused on unlocking the pharmaceutical potential of ketamine, is pleased to announce that the United States Patent …

MindRank Announces Positive Phase 2b Results for AI-Designed Oral GLP-1 Receptor Agonist MDR-001 in Adults with Obesity or Overweight

MindRank Announces Positive Phase 2b Results for AI-Designed Oral GLP-1 Receptor Agonist MDR-001 in Adults with Obesity or Overweight

MDR-001 achieved statistically significant weight reductions of 8.2% to 10.3% at 24 weeks compared to 2.5% with placebo (p<0.00001), with up to 48.1% of participants achieving ≥10% weight loss. No treatment-related serious adverse events were reported. …

Glimpact’s Christophe Girardier to Speak on Building Sustainable Brand-Supplier Relationships at PI Apparel New York 2025

Glimpact’s Christophe Girardier to Speak on Building Sustainable Brand-Supplier Relationships at PI Apparel New York 2025

NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Glimpact, the first platform for analyzing the overall systemic environmental impact of products and organizations, today announced that CEO and Founder Christophe Girardier will speak at PI Apparel New York 2025 …

GoldenMining Launches AI-Driven Cloud Mining Platform to Help Investors Diversify Amid Rising Geopolitical Uncertainty

GoldenMining Launches AI-Driven Cloud Mining Platform to Help Investors Diversify Amid Rising Geopolitical Uncertainty

London, UK, June 24, 2025 (GLOBE NEWSWIRE) -- Amid increasing global instability and geopolitical risk, GoldenMining has officially launched its new AI-driven cloud mining platform, offering investors around the world a powerful, technology-backed tool for …

Brightpick Launches Autopicker 2.0, the First Multi-Purpose Warehouse Robot to Match Human-Level Performance

Brightpick Launches Autopicker 2.0, the First Multi-Purpose Warehouse Robot to Match Human-Level Performance

ERLANGER, Ky., June 24, 2025 (GLOBE NEWSWIRE) -- Brightpick, a leader in AI-powered robotic solutions for warehouses, has unveiled Autopicker 2.0, the most advanced version of its flagship multi-purpose AI robot. Featuring the company’s next-generation …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service